Condition
Bladder Cancer Stage II
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04806334Not ApplicableTerminatedPrimary
Radiogenomics of Muscle Invasive Bladder Cancer
NCT06358599Completed
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy
NCT06170177Recruiting
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
NCT04598724Completed
Addressing Barriers to Palliative Care Use in Bladder Cancer
NCT03522155Not ApplicableUnknown
Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies
Showing all 5 trials